nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—AGTR1—asthma	0.509	1	CbGaD
Eprosartan—CYP2C9—Zileuton—asthma	0.0354	0.155	CbGbCtD
Eprosartan—CYP2C9—Zafirlukast—asthma	0.0312	0.137	CbGbCtD
Eprosartan—CYP2C9—Formoterol—asthma	0.0301	0.132	CbGbCtD
Eprosartan—CYP2C9—Arformoterol—asthma	0.0301	0.132	CbGbCtD
Eprosartan—CYP2C9—Theophylline—asthma	0.0241	0.106	CbGbCtD
Eprosartan—ABCC2—Dexamethasone—asthma	0.0235	0.103	CbGbCtD
Eprosartan—CYP2C9—Montelukast—asthma	0.0228	0.1	CbGbCtD
Eprosartan—CYP2C9—Loratadine—asthma	0.0228	0.1	CbGbCtD
Eprosartan—CYP2C9—Dexamethasone—asthma	0.00789	0.0346	CbGbCtD
Eprosartan—Losartan—AGTR1—asthma	0.00135	0.551	CrCbGaD
Eprosartan—Losartan—ACE—asthma	0.000783	0.318	CrCbGaD
Eprosartan—Losartan—ALB—asthma	0.000321	0.13	CrCbGaD
Eprosartan—AGTR1—GPCR ligand binding—TAC1—asthma	0.0001	0.00148	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—AGER—asthma	9.91e-05	0.00147	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR8—asthma	9.86e-05	0.00146	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TACR2—asthma	9.86e-05	0.00146	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCR3—asthma	9.82e-05	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—asthma	9.44e-05	0.0014	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—asthma	9.42e-05	0.00139	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PMCH—asthma	9.33e-05	0.00138	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PTGDR2—asthma	9.33e-05	0.00138	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HRH4—asthma	9.33e-05	0.00138	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPSR1—asthma	9.33e-05	0.00138	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—asthma	9.22e-05	0.00136	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC26A4—asthma	9.21e-05	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CSF2RB—asthma	9.14e-05	0.00135	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	9.05e-05	0.00134	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—BDKRB2—asthma	8.98e-05	0.00133	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	8.98e-05	0.00133	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TACR2—asthma	8.95e-05	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR8—asthma	8.95e-05	0.00132	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—PDGFB—asthma	8.84e-05	0.00131	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL17—asthma	8.78e-05	0.0013	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4A—asthma	8.61e-05	0.00128	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC30A8—asthma	8.43e-05	0.00125	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ATP4A—asthma	8.43e-05	0.00125	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	8.33e-05	0.00123	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—KNG1—asthma	8.17e-05	0.00121	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	8.09e-05	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CYSLTR1—asthma	8.07e-05	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL10—asthma	7.94e-05	0.00118	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	7.9e-05	0.00117	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4A—asthma	7.82e-05	0.00116	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C5AR1—asthma	7.79e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—VIP—asthma	7.79e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—UTS2—asthma	7.79e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADRB2—asthma	7.71e-05	0.00114	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR4—asthma	7.47e-05	0.00111	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CYSLTR1—asthma	7.33e-05	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—asthma	7.29e-05	0.00108	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2RB—asthma	7.19e-05	0.00106	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4D—asthma	7.13e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—VIP—asthma	7.07e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL11—asthma	7.07e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—UTS2—asthma	7.07e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C5AR1—asthma	7.07e-05	0.00105	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FCER2—asthma	6.98e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3AR1—asthma	6.98e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TACR1—asthma	6.94e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C5—asthma	6.94e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4B—asthma	6.94e-05	0.00103	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—EDN1—asthma	6.89e-05	0.00102	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—asthma	6.83e-05	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR4—asthma	6.78e-05	0.001	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CYSLTR2—asthma	6.72e-05	0.000994	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—ALDH2—asthma	6.53e-05	0.000967	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2RB—asthma	6.53e-05	0.000966	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—asthma	6.5e-05	0.000962	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LTB4R—asthma	6.49e-05	0.00096	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTGDR—asthma	6.49e-05	0.00096	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL22—asthma	6.49e-05	0.00096	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4D—asthma	6.47e-05	0.000958	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR3—asthma	6.35e-05	0.00094	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	6.32e-05	0.000935	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4B—asthma	6.31e-05	0.000933	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C5—asthma	6.31e-05	0.000933	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TACR1—asthma	6.31e-05	0.000933	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTT1—asthma	6.21e-05	0.00092	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPY—asthma	6.19e-05	0.000916	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	6.18e-05	0.000915	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—asthma	6.16e-05	0.000911	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—C3—asthma	6.02e-05	0.000891	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—asthma	5.99e-05	0.000887	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGTR2—asthma	5.97e-05	0.000884	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LTC4S—asthma	5.92e-05	0.000877	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR3—asthma	5.77e-05	0.000854	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—EDNRB—asthma	5.72e-05	0.000846	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CARM1—asthma	5.66e-05	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TAC1—asthma	5.66e-05	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—NPS—asthma	5.66e-05	0.000838	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPY—asthma	5.62e-05	0.000832	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR3—asthma	5.55e-05	0.000822	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRH4—asthma	5.51e-05	0.000816	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTGDR2—asthma	5.51e-05	0.000816	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPSR1—asthma	5.51e-05	0.000816	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PMCH—asthma	5.51e-05	0.000816	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGTR2—asthma	5.42e-05	0.000803	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CSF2RB—asthma	5.4e-05	0.000799	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR8—asthma	5.29e-05	0.000783	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TACR2—asthma	5.29e-05	0.000783	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—asthma	5.27e-05	0.000779	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL5—asthma	5.26e-05	0.000779	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EDNRB—asthma	5.19e-05	0.000769	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL17—asthma	5.18e-05	0.000767	CbGpPWpGaD
Eprosartan—Depression—Prednisone—asthma	5.14e-05	0.000266	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—TAC1—asthma	5.14e-05	0.000761	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—NPS—asthma	5.14e-05	0.000761	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—asthma	5.14e-05	0.00076	CbGpPWpGaD
Eprosartan—Headache—Montelukast—asthma	5.13e-05	0.000265	CcSEcCtD
Eprosartan—Visual impairment—Betamethasone—asthma	5.12e-05	0.000265	CcSEcCtD
Eprosartan—Visual impairment—Dexamethasone—asthma	5.12e-05	0.000265	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—BDKRB2—asthma	5.08e-05	0.000752	CbGpPWpGaD
Eprosartan—Angioedema—Prednisolone—asthma	5.07e-05	0.000262	CcSEcCtD
Eprosartan—Neuropathy peripheral—Prednisone—asthma	5.06e-05	0.000261	CcSEcCtD
Eprosartan—Dizziness—Budesonide—asthma	5.06e-05	0.000261	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CXCR3—asthma	5.04e-05	0.000746	CbGpPWpGaD
Eprosartan—Ill-defined disorder—Hydrocortisone—asthma	5.03e-05	0.00026	CcSEcCtD
Eprosartan—Vomiting—Salbutamol—asthma	5.02e-05	0.000259	CcSEcCtD
Eprosartan—Malaise—Prednisolone—asthma	5e-05	0.000258	CcSEcCtD
Eprosartan—Vertigo—Prednisolone—asthma	4.98e-05	0.000257	CcSEcCtD
Eprosartan—Rash—Salbutamol—asthma	4.98e-05	0.000257	CcSEcCtD
Eprosartan—Syncope—Prednisolone—asthma	4.98e-05	0.000257	CcSEcCtD
Eprosartan—Dermatitis—Salbutamol—asthma	4.97e-05	0.000257	CcSEcCtD
Eprosartan—Nausea—Formoterol—asthma	4.97e-05	0.000257	CcSEcCtD
Eprosartan—Nausea—Arformoterol—asthma	4.97e-05	0.000257	CcSEcCtD
Eprosartan—Angioedema—Hydrocortisone—asthma	4.95e-05	0.000256	CcSEcCtD
Eprosartan—Headache—Salbutamol—asthma	4.95e-05	0.000255	CcSEcCtD
Eprosartan—Back pain—Triamcinolone—asthma	4.93e-05	0.000255	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—ADCY2—asthma	4.91e-05	0.000727	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL3—asthma	4.9e-05	0.000725	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	4.89e-05	0.000724	CbGpPWpGaD
Eprosartan—Malaise—Hydrocortisone—asthma	4.89e-05	0.000252	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisolone—asthma	4.88e-05	0.000252	CcSEcCtD
Eprosartan—Vertigo—Hydrocortisone—asthma	4.87e-05	0.000251	CcSEcCtD
Eprosartan—Nausea—Montelukast—asthma	4.86e-05	0.000251	CcSEcCtD
Eprosartan—Vomiting—Budesonide—asthma	4.86e-05	0.000251	CcSEcCtD
Eprosartan—Syncope—Hydrocortisone—asthma	4.86e-05	0.000251	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	4.83e-05	0.000714	CbGpPWpGaD
Eprosartan—Rash—Budesonide—asthma	4.82e-05	0.000249	CcSEcCtD
Eprosartan—Dermatitis—Budesonide—asthma	4.82e-05	0.000249	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—POMC—asthma	4.81e-05	0.000712	CbGpPWpGaD
Eprosartan—Headache—Budesonide—asthma	4.79e-05	0.000247	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—IL5—asthma	4.78e-05	0.000707	CbGpPWpGaD
Eprosartan—Loss of consciousness—Hydrocortisone—asthma	4.76e-05	0.000246	CcSEcCtD
Eprosartan—Ill-defined disorder—Triamcinolone—asthma	4.73e-05	0.000245	CcSEcCtD
Eprosartan—Ill-defined disorder—Methylprednisolone—asthma	4.72e-05	0.000244	CcSEcCtD
Eprosartan—Bradycardia—Prednisone—asthma	4.71e-05	0.000244	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—asthma	4.71e-05	0.000697	CbGpPWpGaD
Eprosartan—Nausea—Salbutamol—asthma	4.69e-05	0.000242	CcSEcCtD
Eprosartan—Discomfort—Prednisolone—asthma	4.67e-05	0.000241	CcSEcCtD
Eprosartan—Angioedema—Triamcinolone—asthma	4.66e-05	0.000241	CcSEcCtD
Eprosartan—Angioedema—Methylprednisolone—asthma	4.65e-05	0.00024	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—KIF3A—asthma	4.62e-05	0.000684	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE4A—asthma	4.62e-05	0.000684	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—KNG1—asthma	4.62e-05	0.000684	CbGpPWpGaD
Eprosartan—Myalgia—Hydrocortisone—asthma	4.61e-05	0.000238	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—BDKRB2—asthma	4.61e-05	0.000682	CbGpPWpGaD
Eprosartan—Malaise—Triamcinolone—asthma	4.6e-05	0.000238	CcSEcCtD
Eprosartan—Anxiety—Hydrocortisone—asthma	4.6e-05	0.000237	CcSEcCtD
Eprosartan—Malaise—Methylprednisolone—asthma	4.59e-05	0.000237	CcSEcCtD
Eprosartan—Vertigo—Triamcinolone—asthma	4.58e-05	0.000237	CcSEcCtD
Eprosartan—Syncope—Triamcinolone—asthma	4.58e-05	0.000236	CcSEcCtD
Eprosartan—Vertigo—Methylprednisolone—asthma	4.57e-05	0.000236	CcSEcCtD
Eprosartan—Syncope—Methylprednisolone—asthma	4.56e-05	0.000236	CcSEcCtD
Eprosartan—Discomfort—Hydrocortisone—asthma	4.56e-05	0.000235	CcSEcCtD
Eprosartan—Nausea—Budesonide—asthma	4.54e-05	0.000235	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL10—asthma	4.49e-05	0.000664	CbGpPWpGaD
Eprosartan—Loss of consciousness—Triamcinolone—asthma	4.48e-05	0.000232	CcSEcCtD
Eprosartan—Loss of consciousness—Methylprednisolone—asthma	4.47e-05	0.000231	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—ADCY2—asthma	4.46e-05	0.00066	CbGpPWpGaD
Eprosartan—Shock—Prednisolone—asthma	4.45e-05	0.00023	CcSEcCtD
Eprosartan—Cough—Triamcinolone—asthma	4.45e-05	0.00023	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—IL3—asthma	4.45e-05	0.000658	CbGpPWpGaD
Eprosartan—Tachycardia—Prednisolone—asthma	4.42e-05	0.000228	CcSEcCtD
Eprosartan—Hyperhidrosis—Prednisolone—asthma	4.38e-05	0.000226	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—ADRB2—asthma	4.36e-05	0.000645	CbGpPWpGaD
Eprosartan—Shock—Hydrocortisone—asthma	4.35e-05	0.000225	CcSEcCtD
Eprosartan—Myalgia—Triamcinolone—asthma	4.34e-05	0.000224	CcSEcCtD
Eprosartan—Myalgia—Methylprednisolone—asthma	4.33e-05	0.000224	CcSEcCtD
Eprosartan—Arthralgia—Methylprednisolone—asthma	4.33e-05	0.000224	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CYSLTR1—asthma	4.33e-05	0.000641	CbGpPWpGaD
Eprosartan—Anxiety—Methylprednisolone—asthma	4.32e-05	0.000223	CcSEcCtD
Eprosartan—Tachycardia—Hydrocortisone—asthma	4.32e-05	0.000223	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—GSTP1—asthma	4.31e-05	0.000637	CbGpPWpGaD
Eprosartan—Ill-defined disorder—Betamethasone—asthma	4.3e-05	0.000222	CcSEcCtD
Eprosartan—Ill-defined disorder—Dexamethasone—asthma	4.3e-05	0.000222	CcSEcCtD
Eprosartan—Discomfort—Triamcinolone—asthma	4.29e-05	0.000222	CcSEcCtD
Eprosartan—Discomfort—Methylprednisolone—asthma	4.28e-05	0.000221	CcSEcCtD
Eprosartan—Hyperhidrosis—Hydrocortisone—asthma	4.27e-05	0.000221	CcSEcCtD
Eprosartan—Dry mouth—Triamcinolone—asthma	4.25e-05	0.000219	CcSEcCtD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTP1—asthma	4.25e-05	0.000629	CbGpPWpGaD
Eprosartan—Angioedema—Dexamethasone—asthma	4.23e-05	0.000219	CcSEcCtD
Eprosartan—Angioedema—Betamethasone—asthma	4.23e-05	0.000219	CcSEcCtD
Eprosartan—Anorexia—Hydrocortisone—asthma	4.22e-05	0.000218	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ADCY2—asthma	4.2e-05	0.000622	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KNG1—asthma	4.19e-05	0.000621	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—asthma	4.19e-05	0.00062	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CMA1—asthma	4.18e-05	0.000619	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—UTS2—asthma	4.18e-05	0.000619	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL11—asthma	4.18e-05	0.000619	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VIP—asthma	4.18e-05	0.000619	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C5AR1—asthma	4.18e-05	0.000619	CbGpPWpGaD
Eprosartan—Malaise—Betamethasone—asthma	4.17e-05	0.000216	CcSEcCtD
Eprosartan—Malaise—Dexamethasone—asthma	4.17e-05	0.000216	CcSEcCtD
Eprosartan—Vertigo—Betamethasone—asthma	4.16e-05	0.000215	CcSEcCtD
Eprosartan—Vertigo—Dexamethasone—asthma	4.16e-05	0.000215	CcSEcCtD
Eprosartan—Syncope—Dexamethasone—asthma	4.15e-05	0.000214	CcSEcCtD
Eprosartan—Syncope—Betamethasone—asthma	4.15e-05	0.000214	CcSEcCtD
Eprosartan—Hypotension—Hydrocortisone—asthma	4.13e-05	0.000213	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—ITPR1—asthma	4.12e-05	0.00061	CbGpPWpGaD
Eprosartan—Shock—Triamcinolone—asthma	4.1e-05	0.000212	CcSEcCtD
Eprosartan—Insomnia—Prednisolone—asthma	4.1e-05	0.000212	CcSEcCtD
Eprosartan—Shock—Methylprednisolone—asthma	4.09e-05	0.000211	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CXCL10—asthma	4.07e-05	0.000603	CbGpPWpGaD
Eprosartan—Loss of consciousness—Betamethasone—asthma	4.07e-05	0.00021	CcSEcCtD
Eprosartan—Loss of consciousness—Dexamethasone—asthma	4.07e-05	0.00021	CcSEcCtD
Eprosartan—Paraesthesia—Prednisolone—asthma	4.07e-05	0.00021	CcSEcCtD
Eprosartan—Tachycardia—Triamcinolone—asthma	4.06e-05	0.00021	CcSEcCtD
Eprosartan—Tachycardia—Methylprednisolone—asthma	4.05e-05	0.000209	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Hydrocortisone—asthma	4.03e-05	0.000208	CcSEcCtD
Eprosartan—Hyperhidrosis—Triamcinolone—asthma	4.03e-05	0.000208	CcSEcCtD
Eprosartan—Hyperhidrosis—Methylprednisolone—asthma	4.02e-05	0.000207	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CCR4—asthma	4.01e-05	0.000593	CbGpPWpGaD
Eprosartan—Insomnia—Hydrocortisone—asthma	4e-05	0.000207	CcSEcCtD
Eprosartan—Paraesthesia—Hydrocortisone—asthma	3.97e-05	0.000205	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—GSTM1—asthma	3.96e-05	0.000586	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRB2—asthma	3.96e-05	0.000586	CbGpPWpGaD
Eprosartan—Myalgia—Betamethasone—asthma	3.94e-05	0.000204	CcSEcCtD
Eprosartan—Myalgia—Dexamethasone—asthma	3.94e-05	0.000204	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—STAT6—asthma	3.93e-05	0.000582	CbGpPWpGaD
Eprosartan—Anxiety—Dexamethasone—asthma	3.93e-05	0.000203	CcSEcCtD
Eprosartan—Anxiety—Betamethasone—asthma	3.93e-05	0.000203	CcSEcCtD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM1—asthma	3.9e-05	0.000578	CbGpPWpGaD
Eprosartan—Discomfort—Betamethasone—asthma	3.89e-05	0.000201	CcSEcCtD
Eprosartan—Discomfort—Dexamethasone—asthma	3.89e-05	0.000201	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—EDN1—asthma	3.89e-05	0.000576	CbGpPWpGaD
Eprosartan—Dyspepsia—Hydrocortisone—asthma	3.89e-05	0.000201	CcSEcCtD
Eprosartan—Hypotension—Methylprednisolone—asthma	3.88e-05	0.000201	CcSEcCtD
Eprosartan—Pain—Prednisolone—asthma	3.87e-05	0.0002	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—asthma	3.86e-05	0.000572	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2RB—asthma	3.86e-05	0.000571	CbGpPWpGaD
Eprosartan—Decreased appetite—Hydrocortisone—asthma	3.84e-05	0.000199	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—PDE4D—asthma	3.82e-05	0.000566	CbGpPWpGaD
Eprosartan—Fatigue—Hydrocortisone—asthma	3.81e-05	0.000197	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—CSF2—asthma	3.8e-05	0.000563	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Triamcinolone—asthma	3.79e-05	0.000196	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Methylprednisolone—asthma	3.79e-05	0.000196	CcSEcCtD
Eprosartan—Pain—Hydrocortisone—asthma	3.78e-05	0.000195	CcSEcCtD
Eprosartan—Insomnia—Triamcinolone—asthma	3.77e-05	0.000195	CcSEcCtD
Eprosartan—Insomnia—Methylprednisolone—asthma	3.76e-05	0.000194	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—ITPR1—asthma	3.74e-05	0.000554	CbGpPWpGaD
Eprosartan—Ill-defined disorder—Prednisone—asthma	3.74e-05	0.000193	CcSEcCtD
Eprosartan—Paraesthesia—Triamcinolone—asthma	3.74e-05	0.000193	CcSEcCtD
Eprosartan—Feeling abnormal—Prednisolone—asthma	3.73e-05	0.000193	CcSEcCtD
Eprosartan—Paraesthesia—Methylprednisolone—asthma	3.73e-05	0.000193	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—C5—asthma	3.72e-05	0.000551	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE4B—asthma	3.72e-05	0.000551	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TACR1—asthma	3.72e-05	0.000551	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—asthma	3.72e-05	0.000551	CbGpPWpGaD
Eprosartan—Shock—Betamethasone—asthma	3.72e-05	0.000192	CcSEcCtD
Eprosartan—Shock—Dexamethasone—asthma	3.72e-05	0.000192	CcSEcCtD
Eprosartan—Dyspnoea—Triamcinolone—asthma	3.71e-05	0.000192	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	3.71e-05	0.000549	CbGpPWpGaD
Eprosartan—Thrombocytopenia—Dexamethasone—asthma	3.7e-05	0.000191	CcSEcCtD
Eprosartan—Thrombocytopenia—Betamethasone—asthma	3.7e-05	0.000191	CcSEcCtD
Eprosartan—Tachycardia—Betamethasone—asthma	3.69e-05	0.00019	CcSEcCtD
Eprosartan—Tachycardia—Dexamethasone—asthma	3.69e-05	0.00019	CcSEcCtD
Eprosartan—Angioedema—Prednisone—asthma	3.68e-05	0.00019	CcSEcCtD
Eprosartan—Dyspepsia—Triamcinolone—asthma	3.67e-05	0.000189	CcSEcCtD
Eprosartan—Dyspepsia—Methylprednisolone—asthma	3.66e-05	0.000189	CcSEcCtD
Eprosartan—Hyperhidrosis—Dexamethasone—asthma	3.65e-05	0.000189	CcSEcCtD
Eprosartan—Hyperhidrosis—Betamethasone—asthma	3.65e-05	0.000189	CcSEcCtD
Eprosartan—Feeling abnormal—Hydrocortisone—asthma	3.64e-05	0.000188	CcSEcCtD
Eprosartan—Malaise—Prednisone—asthma	3.64e-05	0.000188	CcSEcCtD
Eprosartan—Vertigo—Prednisone—asthma	3.62e-05	0.000187	CcSEcCtD
Eprosartan—Gastrointestinal pain—Hydrocortisone—asthma	3.62e-05	0.000187	CcSEcCtD
Eprosartan—Syncope—Prednisone—asthma	3.62e-05	0.000187	CcSEcCtD
Eprosartan—Anorexia—Dexamethasone—asthma	3.6e-05	0.000186	CcSEcCtD
Eprosartan—Anorexia—Betamethasone—asthma	3.6e-05	0.000186	CcSEcCtD
Eprosartan—Urticaria—Prednisolone—asthma	3.6e-05	0.000186	CcSEcCtD
Eprosartan—Fatigue—Triamcinolone—asthma	3.59e-05	0.000185	CcSEcCtD
Eprosartan—Fatigue—Methylprednisolone—asthma	3.58e-05	0.000185	CcSEcCtD
Eprosartan—Pain—Triamcinolone—asthma	3.56e-05	0.000184	CcSEcCtD
Eprosartan—Loss of consciousness—Prednisone—asthma	3.54e-05	0.000183	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—EDN1—asthma	3.53e-05	0.000523	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HMOX1—asthma	3.53e-05	0.000523	CbGpPWpGaD
Eprosartan—Hypotension—Betamethasone—asthma	3.53e-05	0.000182	CcSEcCtD
Eprosartan—Hypotension—Dexamethasone—asthma	3.53e-05	0.000182	CcSEcCtD
Eprosartan—Urticaria—Hydrocortisone—asthma	3.51e-05	0.000181	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—asthma	3.51e-05	0.000519	CbGpPWpGaD
Eprosartan—Body temperature increased—Hydrocortisone—asthma	3.5e-05	0.000181	CcSEcCtD
Eprosartan—Abdominal pain—Hydrocortisone—asthma	3.5e-05	0.000181	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—PLA2G4A—asthma	3.49e-05	0.000517	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—asthma	3.48e-05	0.000515	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CSF2—asthma	3.45e-05	0.000511	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Dexamethasone—asthma	3.44e-05	0.000178	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Betamethasone—asthma	3.44e-05	0.000178	CcSEcCtD
Eprosartan—Myalgia—Prednisone—asthma	3.43e-05	0.000177	CcSEcCtD
Eprosartan—Arthralgia—Prednisone—asthma	3.43e-05	0.000177	CcSEcCtD
Eprosartan—Feeling abnormal—Triamcinolone—asthma	3.43e-05	0.000177	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—IL2RA—asthma	3.43e-05	0.000508	CbGpPWpGaD
Eprosartan—Feeling abnormal—Methylprednisolone—asthma	3.42e-05	0.000177	CcSEcCtD
Eprosartan—Anxiety—Prednisone—asthma	3.42e-05	0.000177	CcSEcCtD
Eprosartan—Insomnia—Betamethasone—asthma	3.42e-05	0.000177	CcSEcCtD
Eprosartan—Insomnia—Dexamethasone—asthma	3.42e-05	0.000177	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CCR3—asthma	3.41e-05	0.000504	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—asthma	3.4e-05	0.000503	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Methylprednisolone—asthma	3.4e-05	0.000176	CcSEcCtD
Eprosartan—Paraesthesia—Betamethasone—asthma	3.39e-05	0.000175	CcSEcCtD
Eprosartan—Paraesthesia—Dexamethasone—asthma	3.39e-05	0.000175	CcSEcCtD
Eprosartan—Discomfort—Prednisone—asthma	3.39e-05	0.000175	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisolone—asthma	3.34e-05	0.000172	CcSEcCtD
Eprosartan—Dyspepsia—Betamethasone—asthma	3.33e-05	0.000172	CcSEcCtD
Eprosartan—Dyspepsia—Dexamethasone—asthma	3.33e-05	0.000172	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—NPY—asthma	3.32e-05	0.000491	CbGpPWpGaD
Eprosartan—Urticaria—Triamcinolone—asthma	3.31e-05	0.000171	CcSEcCtD
Eprosartan—Urticaria—Methylprednisolone—asthma	3.3e-05	0.000171	CcSEcCtD
Eprosartan—Body temperature increased—Triamcinolone—asthma	3.29e-05	0.00017	CcSEcCtD
Eprosartan—Abdominal pain—Methylprednisolone—asthma	3.28e-05	0.00017	CcSEcCtD
Eprosartan—Decreased appetite—Betamethasone—asthma	3.28e-05	0.00017	CcSEcCtD
Eprosartan—Decreased appetite—Dexamethasone—asthma	3.28e-05	0.00017	CcSEcCtD
Eprosartan—Hypersensitivity—Hydrocortisone—asthma	3.26e-05	0.000168	CcSEcCtD
Eprosartan—Fatigue—Betamethasone—asthma	3.26e-05	0.000168	CcSEcCtD
Eprosartan—Fatigue—Dexamethasone—asthma	3.26e-05	0.000168	CcSEcCtD
Eprosartan—Shock—Prednisone—asthma	3.24e-05	0.000167	CcSEcCtD
Eprosartan—Pain—Betamethasone—asthma	3.23e-05	0.000167	CcSEcCtD
Eprosartan—Pain—Dexamethasone—asthma	3.23e-05	0.000167	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	3.23e-05	0.000477	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	3.23e-05	0.000477	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP2CA—asthma	3.22e-05	0.000476	CbGpPWpGaD
Eprosartan—Tachycardia—Prednisone—asthma	3.21e-05	0.000166	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—AGTR2—asthma	3.2e-05	0.000474	CbGpPWpGaD
Eprosartan—Hyperhidrosis—Prednisone—asthma	3.18e-05	0.000164	CcSEcCtD
Eprosartan—Asthenia—Hydrocortisone—asthma	3.17e-05	0.000164	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—asthma	3.16e-05	0.000468	CbGpPWpGaD
Eprosartan—Anorexia—Prednisone—asthma	3.14e-05	0.000162	CcSEcCtD
Eprosartan—Pruritus—Hydrocortisone—asthma	3.13e-05	0.000162	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—IL2RA—asthma	3.11e-05	0.000461	CbGpPWpGaD
Eprosartan—Feeling abnormal—Dexamethasone—asthma	3.11e-05	0.000161	CcSEcCtD
Eprosartan—Feeling abnormal—Betamethasone—asthma	3.11e-05	0.000161	CcSEcCtD
Eprosartan—Gastrointestinal pain—Dexamethasone—asthma	3.09e-05	0.00016	CcSEcCtD
Eprosartan—Gastrointestinal pain—Betamethasone—asthma	3.09e-05	0.00016	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—C3—asthma	3.09e-05	0.000457	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	3.08e-05	0.000455	CbGpPWpGaD
Eprosartan—Hypersensitivity—Triamcinolone—asthma	3.07e-05	0.000158	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—EDNRB—asthma	3.07e-05	0.000454	CbGpPWpGaD
Eprosartan—Hypersensitivity—Methylprednisolone—asthma	3.06e-05	0.000158	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—TAC1—asthma	3.04e-05	0.000449	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPS—asthma	3.04e-05	0.000449	CbGpPWpGaD
Eprosartan—Diarrhoea—Hydrocortisone—asthma	3.03e-05	0.000156	CcSEcCtD
Eprosartan—Urticaria—Betamethasone—asthma	3e-05	0.000155	CcSEcCtD
Eprosartan—Urticaria—Dexamethasone—asthma	3e-05	0.000155	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Prednisone—asthma	3e-05	0.000155	CcSEcCtD
Eprosartan—Dizziness—Prednisolone—asthma	2.99e-05	0.000155	CcSEcCtD
Eprosartan—Asthenia—Triamcinolone—asthma	2.99e-05	0.000154	CcSEcCtD
Eprosartan—Abdominal pain—Betamethasone—asthma	2.99e-05	0.000154	CcSEcCtD
Eprosartan—Body temperature increased—Betamethasone—asthma	2.99e-05	0.000154	CcSEcCtD
Eprosartan—Abdominal pain—Dexamethasone—asthma	2.99e-05	0.000154	CcSEcCtD
Eprosartan—Body temperature increased—Dexamethasone—asthma	2.99e-05	0.000154	CcSEcCtD
Eprosartan—Asthenia—Methylprednisolone—asthma	2.98e-05	0.000154	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CXCR3—asthma	2.98e-05	0.000441	CbGpPWpGaD
Eprosartan—Insomnia—Prednisone—asthma	2.98e-05	0.000154	CcSEcCtD
Eprosartan—Paraesthesia—Prednisone—asthma	2.95e-05	0.000153	CcSEcCtD
Eprosartan—Pruritus—Triamcinolone—asthma	2.95e-05	0.000152	CcSEcCtD
Eprosartan—Pruritus—Methylprednisolone—asthma	2.94e-05	0.000152	CcSEcCtD
Eprosartan—Dizziness—Hydrocortisone—asthma	2.92e-05	0.000151	CcSEcCtD
Eprosartan—Dyspepsia—Prednisone—asthma	2.9e-05	0.00015	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CYBA—asthma	2.88e-05	0.000427	CbGpPWpGaD
Eprosartan—Decreased appetite—Prednisone—asthma	2.86e-05	0.000148	CcSEcCtD
Eprosartan—Rash—Prednisolone—asthma	2.85e-05	0.000147	CcSEcCtD
Eprosartan—Dermatitis—Prednisolone—asthma	2.85e-05	0.000147	CcSEcCtD
Eprosartan—Diarrhoea—Methylprednisolone—asthma	2.84e-05	0.000147	CcSEcCtD
Eprosartan—Fatigue—Prednisone—asthma	2.84e-05	0.000147	CcSEcCtD
Eprosartan—Headache—Prednisolone—asthma	2.84e-05	0.000147	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—IL5—asthma	2.82e-05	0.000418	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PARP1—asthma	2.82e-05	0.000418	CbGpPWpGaD
Eprosartan—Constipation—Prednisone—asthma	2.81e-05	0.000145	CcSEcCtD
Eprosartan—Vomiting—Hydrocortisone—asthma	2.81e-05	0.000145	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—POMC—asthma	2.8e-05	0.000414	CbGpPWpGaD
Eprosartan—Rash—Hydrocortisone—asthma	2.79e-05	0.000144	CcSEcCtD
Eprosartan—Dermatitis—Hydrocortisone—asthma	2.79e-05	0.000144	CcSEcCtD
Eprosartan—Headache—Hydrocortisone—asthma	2.77e-05	0.000143	CcSEcCtD
Eprosartan—Dizziness—Triamcinolone—asthma	2.75e-05	0.000142	CcSEcCtD
Eprosartan—Dizziness—Methylprednisolone—asthma	2.75e-05	0.000142	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	2.74e-05	0.000406	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BDKRB2—asthma	2.72e-05	0.000403	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—asthma	2.72e-05	0.000403	CbGpPWpGaD
Eprosartan—Feeling abnormal—Prednisone—asthma	2.71e-05	0.00014	CcSEcCtD
Eprosartan—Asthenia—Betamethasone—asthma	2.71e-05	0.00014	CcSEcCtD
Eprosartan—Asthenia—Dexamethasone—asthma	2.71e-05	0.00014	CcSEcCtD
Eprosartan—Gastrointestinal pain—Prednisone—asthma	2.69e-05	0.000139	CcSEcCtD
Eprosartan—Nausea—Prednisolone—asthma	2.69e-05	0.000139	CcSEcCtD
Eprosartan—Pruritus—Dexamethasone—asthma	2.67e-05	0.000138	CcSEcCtD
Eprosartan—Pruritus—Betamethasone—asthma	2.67e-05	0.000138	CcSEcCtD
Eprosartan—Vomiting—Triamcinolone—asthma	2.65e-05	0.000137	CcSEcCtD
Eprosartan—Vomiting—Methylprednisolone—asthma	2.64e-05	0.000136	CcSEcCtD
Eprosartan—CYP2C9—Metabolism—LTC4S—asthma	2.64e-05	0.000391	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADCY2—asthma	2.64e-05	0.00039	CbGpPWpGaD
Eprosartan—Nausea—Hydrocortisone—asthma	2.63e-05	0.000136	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—IL3—asthma	2.63e-05	0.000389	CbGpPWpGaD
Eprosartan—Rash—Triamcinolone—asthma	2.63e-05	0.000136	CcSEcCtD
Eprosartan—Dermatitis—Triamcinolone—asthma	2.62e-05	0.000136	CcSEcCtD
Eprosartan—Rash—Methylprednisolone—asthma	2.62e-05	0.000135	CcSEcCtD
Eprosartan—Dermatitis—Methylprednisolone—asthma	2.62e-05	0.000135	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	2.62e-05	0.000387	CbGpPWpGaD
Eprosartan—Urticaria—Prednisone—asthma	2.61e-05	0.000135	CcSEcCtD
Eprosartan—Headache—Triamcinolone—asthma	2.61e-05	0.000135	CcSEcCtD
Eprosartan—Headache—Methylprednisolone—asthma	2.6e-05	0.000134	CcSEcCtD
Eprosartan—Body temperature increased—Prednisone—asthma	2.6e-05	0.000134	CcSEcCtD
Eprosartan—Abdominal pain—Prednisone—asthma	2.6e-05	0.000134	CcSEcCtD
Eprosartan—Diarrhoea—Dexamethasone—asthma	2.58e-05	0.000134	CcSEcCtD
Eprosartan—Diarrhoea—Betamethasone—asthma	2.58e-05	0.000134	CcSEcCtD
Eprosartan—Dizziness—Betamethasone—asthma	2.5e-05	0.000129	CcSEcCtD
Eprosartan—Dizziness—Dexamethasone—asthma	2.5e-05	0.000129	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—KNG1—asthma	2.48e-05	0.000367	CbGpPWpGaD
Eprosartan—Nausea—Triamcinolone—asthma	2.47e-05	0.000128	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—POMC—asthma	2.47e-05	0.000366	CbGpPWpGaD
Eprosartan—Nausea—Methylprednisolone—asthma	2.47e-05	0.000127	CcSEcCtD
Eprosartan—Hypersensitivity—Prednisone—asthma	2.42e-05	0.000125	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—asthma	2.42e-05	0.000358	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6R—asthma	2.41e-05	0.000357	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL10—asthma	2.41e-05	0.000356	CbGpPWpGaD
Eprosartan—Vomiting—Betamethasone—asthma	2.4e-05	0.000124	CcSEcCtD
Eprosartan—Vomiting—Dexamethasone—asthma	2.4e-05	0.000124	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—RHOA—asthma	2.4e-05	0.000355	CbGpPWpGaD
Eprosartan—Rash—Dexamethasone—asthma	2.38e-05	0.000123	CcSEcCtD
Eprosartan—Rash—Betamethasone—asthma	2.38e-05	0.000123	CcSEcCtD
Eprosartan—Dermatitis—Dexamethasone—asthma	2.38e-05	0.000123	CcSEcCtD
Eprosartan—Dermatitis—Betamethasone—asthma	2.38e-05	0.000123	CcSEcCtD
Eprosartan—Headache—Betamethasone—asthma	2.37e-05	0.000122	CcSEcCtD
Eprosartan—Headache—Dexamethasone—asthma	2.37e-05	0.000122	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—NTRK1—asthma	2.36e-05	0.00035	CbGpPWpGaD
Eprosartan—Asthenia—Prednisone—asthma	2.36e-05	0.000122	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—ADRB2—asthma	2.34e-05	0.000346	CbGpPWpGaD
Eprosartan—Pruritus—Prednisone—asthma	2.33e-05	0.00012	CcSEcCtD
Eprosartan—CYP2C9—Metabolism—LTA4H—asthma	2.29e-05	0.000339	CbGpPWpGaD
Eprosartan—Diarrhoea—Prednisone—asthma	2.25e-05	0.000116	CcSEcCtD
Eprosartan—Nausea—Betamethasone—asthma	2.24e-05	0.000116	CcSEcCtD
Eprosartan—Nausea—Dexamethasone—asthma	2.24e-05	0.000116	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—ITPR1—asthma	2.21e-05	0.000327	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RHOA—asthma	2.18e-05	0.000322	CbGpPWpGaD
Eprosartan—Dizziness—Prednisone—asthma	2.18e-05	0.000112	CcSEcCtD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—asthma	2.12e-05	0.000314	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CD86—asthma	2.1e-05	0.000312	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—asthma	2.1e-05	0.000311	CbGpPWpGaD
Eprosartan—Vomiting—Prednisone—asthma	2.09e-05	0.000108	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—EDN1—asthma	2.09e-05	0.000309	CbGpPWpGaD
Eprosartan—Rash—Prednisone—asthma	2.07e-05	0.000107	CcSEcCtD
Eprosartan—Dermatitis—Prednisone—asthma	2.07e-05	0.000107	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CCL5—asthma	2.07e-05	0.000307	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLA2G4A—asthma	2.06e-05	0.000306	CbGpPWpGaD
Eprosartan—Headache—Prednisone—asthma	2.06e-05	0.000106	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—CSF2—asthma	2.04e-05	0.000302	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—asthma	2.01e-05	0.000298	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ARG1—asthma	2e-05	0.000296	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SMAD3—asthma	1.99e-05	0.000294	CbGpPWpGaD
Eprosartan—Nausea—Prednisone—asthma	1.95e-05	0.000101	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—asthma	1.91e-05	0.000283	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP2CA—asthma	1.9e-05	0.000281	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—asthma	1.87e-05	0.000276	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2RA—asthma	1.84e-05	0.000272	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—asthma	1.83e-05	0.00027	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—asthma	1.82e-05	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH7A1—asthma	1.81e-05	0.000268	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDGFB—asthma	1.78e-05	0.000263	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ARG2—asthma	1.73e-05	0.000257	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—asthma	1.7e-05	0.000251	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FN1—asthma	1.6e-05	0.000237	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	1.52e-05	0.000225	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—asthma	1.46e-05	0.000216	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX5AP—asthma	1.44e-05	0.000213	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX15—asthma	1.44e-05	0.000213	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—asthma	1.43e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6R—asthma	1.42e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EGFR—asthma	1.4e-05	0.000207	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CHAT—asthma	1.37e-05	0.000203	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—asthma	1.33e-05	0.000197	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RHOA—asthma	1.29e-05	0.00019	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—asthma	1.27e-05	0.000188	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX5—asthma	1.22e-05	0.000181	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CARM1—asthma	1.17e-05	0.000172	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DCN—asthma	1.15e-05	0.00017	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—asthma	1.13e-05	0.000167	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH2—asthma	1.12e-05	0.000165	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—asthma	1.08e-05	0.00016	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	1.07e-05	0.000159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—asthma	1.07e-05	0.000159	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTT1—asthma	1.06e-05	0.000157	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—asthma	1.02e-05	0.000151	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTEN—asthma	1.01e-05	0.00015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	9.79e-06	0.000145	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—asthma	9.17e-06	0.000136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT3—asthma	9.08e-06	0.000134	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NQO1—asthma	8.83e-06	0.000131	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADCY2—asthma	8.64e-06	0.000128	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.57e-06	0.000127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—asthma	8.41e-06	0.000125	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EGFR—asthma	8.25e-06	0.000122	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	7.47e-06	0.000111	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTP1—asthma	7.36e-06	0.000109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—asthma	7.26e-06	0.000108	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ITPR1—asthma	7.25e-06	0.000107	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—asthma	7.17e-06	0.000106	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G4A—asthma	6.77e-06	0.0001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—asthma	6.77e-06	0.0001	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—asthma	6.34e-06	9.38e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPP2CA—asthma	6.23e-06	9.23e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—asthma	4.78e-06	7.08e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—asthma	4.36e-06	6.46e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—asthma	4.17e-06	6.18e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—asthma	3.82e-06	5.65e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTEN—asthma	3.33e-06	4.93e-05	CbGpPWpGaD
